Vanguard Group’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
1,807,582
+1,777,096
| +5,829% | +$17.8M | ﹤0.01% | 2601 |
|
|
2025
Q1 | $2.68M | Buy |
30,486
+1,860
| +6% | +$163K | ﹤0.01% | 3388 |
|
|
2024
Q4 | $2.66M | Sell |
28,626
-4,285
| -13% | -$397K | ﹤0.01% | 3482 |
|
|
2024
Q3 | $2.41M | Buy |
32,911
+1,331
| +4% | +$97.4K | ﹤0.01% | 3496 |
|
|
2024
Q2 | $1.83M | Buy |
31,580
+12,372
| +64% | +$719K | ﹤0.01% | 3587 |
|
|
2024
Q1 | $19.9M | Buy |
19,208
+1,299
| +7% | +$1.34M | ﹤0.01% | 2602 |
|
|
2023
Q4 | $14.2M | Buy |
17,909
+792
| +5% | +$627K | ﹤0.01% | 2761 |
|
|
2023
Q3 | $8.13M | Buy |
17,117
+2,158
| +14% | +$1.02M | ﹤0.01% | 3000 |
|
|
2023
Q2 | $8.98M | Buy |
14,959
+293
| +2% | +$176K | ﹤0.01% | 3007 |
|
|
2023
Q1 | $10.4M | Buy |
14,666
+395
| +3% | +$279K | ﹤0.01% | 2917 |
|
|
2022
Q4 | $14.6M | Buy |
14,271
+950
| +7% | +$974K | ﹤0.01% | 2781 |
|
|
2022
Q3 | $7.73M | Buy |
13,321
+681
| +5% | +$395K | ﹤0.01% | 3086 |
|
|
2022
Q2 | $6.92M | Sell |
12,640
-1,077
| -8% | -$589K | ﹤0.01% | 3193 |
|
|
2022
Q1 | $8.8M | Buy |
13,717
+337
| +3% | +$216K | ﹤0.01% | 3219 |
|
|
2021
Q4 | $5.52M | Sell |
13,380
-8,945
| -40% | -$3.69M | ﹤0.01% | 3551 |
|
|
2021
Q3 | $16.4M | Buy |
+22,325
| New | +$16.4M | ﹤0.01% | 2970 |
|